Acurx Pharmaceuticals, Inc. (ACXP)
NASDAQ: ACXP · Real-Time Price · USD
3.210
-0.270 (-7.76%)
At close: Dec 5, 2025, 4:00 PM EST
3.220
+0.010 (0.31%)
After-hours: Dec 5, 2025, 7:55 PM EST
Acurx Pharmaceuticals Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Selling, General & Admin | 6.87 | 8.7 | 8.53 | 7.34 | 10.78 | 2.4 | |
| Research & Development | 2.38 | 5.4 | 6.04 | 4.75 | 2.03 | 2.2 | |
| Operating Expenses | 9.25 | 14.1 | 14.58 | 12.09 | 12.81 | 4.6 | |
| Operating Income | -9.25 | -14.1 | -14.58 | -12.09 | -12.81 | -4.6 | |
| EBT Excluding Unusual Items | -9.17 | -14.1 | -14.58 | -12.09 | -12.81 | -4.6 | |
| Other Unusual Items | - | - | - | - | 0.07 | - | |
| Pretax Income | -9.17 | -14.1 | -14.58 | -12.09 | -12.75 | -4.6 | |
| Net Income | -9.17 | -14.1 | -14.58 | -12.09 | -12.75 | -4.6 | |
| Net Income to Common | -9.17 | -14.1 | -14.58 | -12.09 | -12.75 | -4.6 | |
| Shares Outstanding (Basic) | 1 | 1 | 1 | 1 | 0 | 0 | |
| Shares Outstanding (Diluted) | 1 | 1 | 1 | 1 | 0 | 0 | |
| Shares Change (YoY) | 51.82% | 27.56% | 17.15% | 26.72% | 37.88% | 30.29% | |
| EPS (Basic) | -7.85 | -17.45 | -23.01 | -22.36 | -29.87 | -14.86 | |
| EPS (Diluted) | -7.85 | -17.45 | -23.01 | -22.36 | -29.87 | -14.86 | |
| EBIT | -9.25 | -14.1 | -14.58 | -12.09 | -12.81 | -4.6 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.